Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?

Pierre-Henry Gabrielle1, Catherine Creuzot-Garcher2

  • 1Department of Ophthalmology, Dijon University Hospital, Dijon, France; Eye and Nutrition Research Group, CSGA, UMR 1324 INRA, 6265 CNRS, Burgundy University, Dijon, France; Save Sight Institute, Discipline of Ophthalmology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

PubMed
Abstract

No abstract available in PubMed .